Mithra Pharmaceuticals S.A.
MITPF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$173,502 | -$59,620 | -$116,875 | -$92,086 |
| Dep. & Amort. | $12,214 | $11,940 | $10,426 | $9,873 |
| Deferred Tax | $0 | -$56,989 | -$15,766 | -$38,466 |
| Stock-Based Comp. | $4,540 | $1,983 | $1,065 | $7,267 |
| Change in WC | $0 | -$31,126 | $6,151 | -$11,453 |
| Other Non-Cash | $154,564 | $67,131 | $28,847 | $41,337 |
| Operating Cash Flow | -$2,184 | -$66,681 | -$86,152 | -$83,528 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$25,658 | -$21,182 | -$16,230 |
| Net Acquisitions | $0 | $169 | $0 | $23 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3,452 | -$1 | -$33,500 | -$5,562 |
| Investing Cash Flow | $3,452 | -$25,490 | -$54,682 | -$16,207 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $45,425 | $25,799 | $121,526 |
| Stock Issued | $0 | $36,369 | $9,213 | $65,731 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$20,538 | -$3,925 | -$2 | $1,433 |
| Financing Cash Flow | -$20,538 | $87,731 | $35,010 | $188,690 |
| Forex Effect | -$35 | -$147 | $21 | $0 |
| Net Chg. in Cash | -$19,305 | -$4,587 | -$105,803 | $88,955 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,285 | $32,872 | $138,675 | $49,720 |
| End Cash | $8,980 | $28,285 | $32,872 | $138,675 |
| Free Cash Flow | -$2,184 | -$92,339 | -$107,334 | -$99,758 |